Evidence map›Paper›PMID 35295233›Full record

ArticleERJ open research2022

Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel.

Elena Kum, Gordon H Guyatt, Caroline Munoz, Suzanne Beaudin, Shelly-Anne Li, Rayid Abdulqawi, Huda Badri, Louis-Philippe Boulet, Ruchong Chen, Peter Dicpinigaitis and 11 more

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 8 countries.

Elena KumDept of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0002-6548-2632
Gordon H GuyattDept of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Caroline MunozDept of Medicine, McMaster University, Hamilton, ON, Canada.
Suzanne BeaudinDept of Medicine, McMaster University, Hamilton, ON, Canada.
Shelly-Anne LiLawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.
Rayid AbdulqawiKing Fahad Specialist Hospital-Dammam and Dept of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Huda BadriDivision of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-6134-4347
Louis-Philippe BouletQuébec Heart and Lung Institute, Laval University, Quebec City, QC, Canada.
Ruchong ChenDept of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0001-5376-8230
Peter DicpinigaitisAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.ORCID https://orcid.org/0000-0001-5318-9060
Lieven DupontDept of Respiratory Diseases, University Hospital Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
Stephen K FieldDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Cynthia L FrenchDivision of Pulmonary, Allergy, and Critical Care Medicine, Dept of Medicine, UMass Memorial Medical Center, Worcester, MA, USA.
Peter G GibsonPriority Research Centre for Asthma and Respiratory Diseases and Hunter Medical Research Institute, Faculty of Health and Medicine, The University of Newcastle, Callaghan, NSW, Australia.ORCID https://orcid.org/0000-0001-5865-489X
Richard S IrwinDivision of Pulmonary, Allergy, and Critical Care Medicine, Dept of Medicine, UMass Memorial Medical Center, Worcester, MA, USA.
Paul MarsdenDivision of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
Lorcan McGarveyCentre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Jaclyn A SmithDivision of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0001-8837-4928
Woo-Jung SongDept of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4630-9922
Paul M O'ByrneDept of Medicine, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-0979-281X
Imran SatiaDept of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-4206-6000
Impact · CAUniversity of Manchester · GBMcMaster University · CAUMass Memorial Health Care · USAlbert Einstein College of Medicine · USAlfaisal University · SAFirst Affiliated Hospital of Guangzhou Medical University · CNHunter Medical Research Institute · AUKU Leuven · BEQueen's University Belfast · GBSt. Joseph’s Healthcare Hamilton · CAUlsan College · KRUniversité Laval · CAUniversity of Calgary · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cough symptom severity represents an important subjective end-point to assess the impact of therapies for patients with refractory or unexplained chronic cough (RCC/UCC). As existing instruments assessing the severity of cough are neither widely available nor tested for measurement properties, we aim to develop a new patient-reported outcome measure addressing cough severity. Objective: The aim of this study was to establish items and domains that would inform development of a new cough severity instrument. Methods: Three focus groups involving 16 adult patients with RCC/UCC provided data that we analysed using directed content analysis. Discussions led to consensus among an international panel of 15 experts on candidate items and domains to assess cough severity. Results: The patient focus group provided 48 unique items arranged under broad domains of urge-to-cough sensations and cough symptom. Feedback from expert panel members confirmed the appropriateness of items and domains, and provided an additional subdomain related to cough triggers. The final conceptual framework comprised 51 items in the following domains: urge-to-cough sensations (subdomains: frequency and intensity) and cough symptom (subdomains: triggers, control, frequency, fit/bout duration, intensity, quality and associated features/sequelae). Conclusions: Consensus findings from patients and international experts established domains of urge-to-cough and cough symptom with associated subdomains and relevant items. The results support item generation and content validity for a novel patient-reported outcome measure for use in health research and clinical practice.

Identifiers

PMID35295233
PMCPMC8918938
OpenAlexW4210460524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.